⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 31, 2021International Journal of Cardiology and Cardiovascular Diseases

Implications of ATPCI study on trimetazidine use in clinical practice

View at Publisher

Ask AI

Bookmark

Share

Abstract

The ATPCI (efficAcy and safety of Trimetazidine in patients with angina pectoris treated by Percutaneous Coronary Intervention) study reported similar primary outcomes between trimetazidine and placebo groups in patients with angina who recently had a percutaneous coronary intervention, but the results of this study reconfirmed the safety of trimetazidine

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2021 study studied this question.

synapsesocial.com/papers/6a1cc7546552df3dce1d9dc5 https://doi.org/10.46439/cardiology.1.014

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Diagnosis of hyperprolactinemia by single serum prolactin determination: Challenges and recommendationsInternational Journal of Cardiology and Cardiovascular Diseases · Mon,
2Myocardial work by 2 echocardiogram in different pathologiesInternational Journal of Cardiology and Cardiovascular Diseases · Mon,
3Level of adherence to lifestyle modifications and associated factors among hypertensive patients attending outpatient department at Bishoftu General Hospital, Oromia Region, Ethiopia, 2022International Journal of Cardiology and Cardiovascular Diseases · Fri,
4Mechanisms of troponin release into serum in cardiac injury associated with COVID-19 patientsInternational Journal of Cardiology and Cardiovascular Diseases · Mon,
5High-resolution 3D fluorescent imaging of intact tissuesInternational Journal of Cardiology and Cardiovascular Diseases · Mon,